The VP Global Regulatory Affairs is accountable for the integrated worldwide regulatory strategy, leadership, and delivery for the company’s pipeline of therapies targeting immune-mediated diseases. This executive will establish a globally coherent strategy while addressing country- and region-specific requirements across U.S., China, Asia-Pacific, Europe, and other priority regions.
The role is responsible for planning and executing INDs, CTAs, and related submissions; guiding first-in-human and early clinical development regulatory strategies; and defining the path through proof-of-concept, later-stage development, marketing authorization, and lifecycle management.
The role requires deep expertise in global drug development regulations, strong scientific and regulatory judgment, and the ability to drive high-quality execution across multiple geographies, cultures, and health-authority frameworks. This leader will build a world-class Global Regulatory Affairs function and ensure coordinated global and regional execution.
Working through cross-functional and regional development teams, the VP Global Regulatory Affairs will provide unified regulatory leadership across the portfolio. This executive will integrate scientific, medical, clinical, CMC, safety, translational, commercial, and market-access considerations into coherent global strategies and executable regional plans.
These plans will align with each program’s vision, Target Product Profile, and value proposition; establish the optimal sequence of submissions across priority markets; define clear global and regional objectives, decision criteria, and accountabilities; identify and mitigate critical risks and dependencies; and support timely, evidence-based decisions at key investment, submission, and governance milestones.
The VP Global Regulatory Affairs will lead by influence across functions and geographies. They will create a high-performing Global Regulatory Affairs team with clear global and regional accountabilities, transparent decision-making, and strong execution discipline.
This leader will work closely with Research, Pre-clinical Development, Clinical Development, Clinical Operations, Translational Medicine, Biomarkers, Clinical Pharmacology, CMC, Safety, DMPK, Quality, Project Management, Finance, and Business Development; align regional regulatory leads and external representatives; represent regulatory strategy at senior governance forums and with partners; and serve as a senior company representative in interactions with FDA, NMPA, EMA, and other health authorities worldwide.
This role reports to the Chief Medical Officer.
Ailux is an innovative biotechnology company harnessing AI to accelerate breakthrough biologic therapies in difficult immune-mediated diseases and improve the lives of patients with significant unmet medical need.
Built on intelligent design and guided by people who care about transforming healthcare, our technology is redefining what is possible in biologics development, from how we select targets to how we engineer the molecules.Ailux’s vision is to light the path to new cures and fundamentally change our approach to science and drug development to redefine current treatment paradigms.
We look to continue unlocking the potential of disease biology, integrate AI-enabled biologics development, and deliver effective clinical execution.Backed by an experienced leadership team, leading scientific advisors, a highly multidisciplinary organization, and strategic partnerships in biopharma, Ailux is approaching a key inflection point as its first wave of therapeutic programs advance toward clinical development.
This is an opportunity to play a vital role in leading programs from pre-clinical development into the clinic and through clinical proof-of-concept, shaping the pipeline and development culture of a rapidly growing biotechnology company.